Evaluation of cell-free fetal DNA to determine fetal RhD status
contributed by Revvity |
Fetal Rhesus Factor D (RhD) genotyping is typically performed through non-invasive prenatal testing (NIPT) and is important in identifying RhD incompatibility between mother and child.
The FetoGnost® Kit RHD from Ingenetix allows rapid, sensitive, and non-invasive fetal RhD genotyping of samples purified from maternal plasma of RhD-negative pregnant women, based on real-time PCR technology. In this app note, you will explore the compatibility of the FetoGnost® Kit RHD with extracted cffDNA obtained with the chemagic™ 360 instrument using RhD-positive or -negative plasma from blood donors.
Log in or register to gain full unlimited access to all content on the The Pathologist site. It’s FREE!